Article info
PDFResearch ethics
Subjects’ views of obligations to ensure post-trial access to drugs, care and information: qualitative results from the Experiences of Participants in Clinical Trials (EPIC) study
- Dr J S Weissman, Institute for Health Policy, Massachusetts General Hospital, 50 Staniford Street, 9th Floor, Boston, MA 02114, USA; jweissman{at}partners.org
Citation
Subjects’ views of obligations to ensure post-trial access to drugs, care and information: qualitative results from the Experiences of Participants in Clinical Trials (EPIC) study
Publication history
- Received February 4, 2008
- Revised August 14, 2008
- Accepted August 28, 2008
- First published February 27, 2009.
Online issue publication
February 27, 2009
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2009 BMJ Publishing Group & Institute of Medical Ethics
Other content recommended for you
- Implementing post-trial access plans for HIV prevention research
- Investigation of post-trial access views among study participants and stakeholders using photovoice and semistructured interviews
- ‘Ethical responsibility’ or ‘a whole can of worms’: differences in opinion on incidental finding review and disclosure in neuroimaging research from focus group discussions with participants, parents, IRB members, investigators, physicians and community members
- Phase I oncology trials: why the therapeutic misconception will not go away
- How to write a systematic review of reasons
- Should post-trial provision of beneficial experimental interventions be mandatory in developing countries?
- Challenges with participant reimbursement: experiences from a post-trial access study
- Forthcoming practical framework for ethics committees and researchers on post-trial access to the trial intervention and healthcare
- Developing ethics guidance for HIV prevention research: the HIV Prevention Trials Network approach
- Post-trial access to study medication: a Brazilian e-survey with major stakeholders in clinical research